Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Human Vaccine - Market Opportunity Analysis and Forecast | Technavio

Technavio Research
Posted on: 10 Mar 18

Market research firm Technavio has announced the release of their latest report on the global human vaccine market. This new report will provide in-depth market insights for the forecast period 2018-2022.

This press release features multimedia. View the full release here:

Technavio has published a new market research report on the global human vaccine market from 2018-2022. (Graphic: Business Wire)

The new report will follow-up on Technavio’s previous report, helping businesses to align with the rapidly changing market trends and expand their market shares in untapped segments. It will also provide a deep understanding of the multiple factors impacting the growth of the market across the globe.

The updated research report on the global human vaccine market is an integral part of Technavio’s vaccines portfolio. Technavio covers a wide range of market research reports on the vaccines market, highlighting the current market dynamics for the industry. Some of the topics covered include cephalosporin drugs, influenza vaccine, cholera vaccine, and human combination vaccine.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy2 reports and get the third for FREE: View all Technavio’s current offers

Global opportunities for growth

Technavio’s previous report on the global human vaccine market projected the Americas to be the largest market for human vaccines. The high incidences of infectious diseases and cancers in regions such as the US, Canada, and Latin America was considered as a significant factor, which resulted in the region’s impressive market share.

In the previous report, a senior research analyst at Technavio stated, “Increasing public awareness and support from both government and non-government agencies will drive the prospects for growth in this market. Lately, it has been observed that many programs and camps are being organized to spread awareness about the benefits of vaccination. This increase in awareness will assist to augment the vaccination coverage across the world.”

Technavio’s new report on the global human vaccine market will evaluate the key geographical regions and their behavior over the past four years, introducing new data and observations and providing new predictions.

Looking for the latest information on the global human vaccine market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Detailed analysis at your fingertips

Some of the topics that will be revisited in the new report include:

  • Market size and growth rate through 2022
  • Key drivers for the market
  • Competitive landscape and financial analysis of the major players
  • Market opportunities and factors impeding growth

Technavio’s report on the global human vaccine market for the period 2018-2022 is available to order now and will be delivered within one week of purchase.


Technavio’s best deals of the month!

Celebrate Earth Day and clean energy with Technavio. Get 30% discounton all Energy reports. Offer valid from 12th March - 18th March.


Get 20% off on all Media and Entertainment Services reports. Offer valid only till the 31st of March.


About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at

View source version on

Business Wire

Last updated on: 10/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.